01 1Zhejiang Haisen Pharmaceutical Co., Ltd.
01 1ATORVASTATIN CALCIUM
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-09-27
Pay. Date : 2022-03-16
DMF Number : 36416
Submission : 2021-10-28
Status : Active
Type : II
20
Zhejiang Haisen Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ATORVASTATIN CALCIUM, with a corresponding US DMF Number 36416.
Remarkably, this DMF maintains an Active status since its submission on October 28, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 27, 2022, and payment made on March 16, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
